FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: REA Group Gets Lower Fiscal 2027 Profit Forecast From Citi

By

REA Group (ASX:REA) received a 6% reduction in fiscal 2027 net profit forecast from Citi analyst Siraj Ahmed, with the analyst citing a near-term impact on the company's earnings due to the Australian Government's proposed negative gearing and capital gains tax changes, the Australian Financial Review reported Friday.

Ahmed maintained his buy recommendation on REA Group but lowered his target price by 10% to AU$181.15 as the market's reaction has been "excessive" after the company's shares fell 15% since the federal budget was handed down.

The impact is expected to be primarily a one-off, with increased turnover from positively geared investors and owner-occupiers, according to Citi.

The company anticipated housing listings to fall 5% in fiscal 2027 due to longer holding periods among negatively geared property investors, who account for roughly 40% of Australia's 3.3 million investment properties.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

Kim Forest Enterprise Wins NT$110 Million Genome Sequencing Kit Supply Deal

Kim Forest Enterprise (TPE:6645) won a tender to supply whole genome sequencing assay kits to a national hospital in Taiwan under a contract worth NT$110 million, according to a Wednesday Taiwan Exchange filing.Shares slid about 2% in Thursday's late morning trade.The contract runs from June 10, 2026, to Dec. 31, 2028.Kim Forest said the deal is expected to expand its business operations and boost revenue.

$TPE:6645
Asia

Beijing Balance Medical Tech to Buy Back Up to 100 Million Yuan Worth of Shares

Beijing Balance Medical Technology (SHA:688198) plans to repurchase shares worth between 50 million yuan and 100 million yuan, according to a Shanghai bourse filing on Thursday.The company will buy back between 359,583 shares and 719,165 shares, which represents 0.26% to 0.52% of the company's total shares, within 12 months after the approval of the board of directors.The maximum repurchase price will be 139.05 yuan per share.The repurchased shares will be used for the company's employee stock ownership plan or equity incentives.The medical device manufacturer's shares rose 1% during the morning trade.

$SHA:688198
Asia

MediaTek's Sales Edge Up in April; Shares Drop 3%

MediaTek (TPE:2454) booked consolidated net sales of NT$47.4 billion in May, up 1.5% from NT$46.7 billion in April, according to a Wednesday Taiwan Exchange filing.Shares slid about 3% in Thursday's late morning trade.MediaTek did not provide further details in the filing.

$TPE:2454